Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors - Concepedia

Concepedia

Publication | Closed Access

Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors

94

Citations

15

References

2015

Year

Yutaka Fujiwara, Hiroshi Nokihara, Yasuhide Yamada, Noboru Yamamoto, Kuniko Sunami, Hirofumi Utsumi, Hiroya Asou, Osamu Takahashi, K. OGASAWARA, Ivelina Gueorguieva,

Cancer Chemotherapy and Pharmacology

MedicineMetronomic TherapyPharmacologyCancer GrowthPathologyCancer TreatmentTgf-beta ReceptorOncologyRadiation OncologyPhase 1Cancer ResearchJapanese Patients

References

	Year	Citations

Page 1

Page 1